ST6Gal-I is upregulated in multiple cancers, including ovarian, pancreatic, and colon (3, 10, 11, 12, 13), and high expression of this enzyme correlates with a poor patient prognosis (3, 11, 12, 13). Here, ST6GAL1 is linked to cancer.